|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.85 USD | 0.00% |
|
+3.35% | -2.63% |
| 04-18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
| 04-15 | I-Mab Announces Chief Medical Officer Changes | CI |
I-Mab (NasdaqGM:IMAB) announces a share repurchase program. Under the program, the company will repurchase up to $40 million worth of its ordinary shares or American depositary shares. The purpose of the program is to enhance long-term shareholder's value.
The program will be valid for 12 months.
| 1st Jan change | Capi. | |
|---|---|---|
| -2.63% | 149M | |
| +31.37% | 588B | |
| -2.73% | 364B | |
| +20.41% | 326B | |
| +5.48% | 285B | |
| +14.83% | 239B | |
| +9.93% | 210B | |
| -6.95% | 200B | |
| +11.13% | 167B | |
| +0.45% | 161B |
I-MAB 
